These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 16405039)

  • 1. [Functional changes of myocardial adrenoreceptors in patients with chronic cardiac insufficiency].
    Starodubtsev AK; Arkhipova DE; Sychev DA; Maksimov ML; Mchkin IA
    Eksp Klin Farmakol; 2005; 68(6):59-66. PubMed ID: 16405039
    [No Abstract]   [Full Text] [Related]  

  • 2. [Role of intermediate metabolic changes in the mechanism of cardiac insufficiency and cardiac glycoside toxicity].
    Pogosian LA
    Zh Eksp Klin Med; 1965; 5(3):31-6. PubMed ID: 5847709
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical and morpho-biochemical aspects of chronic cardiac insufficiency in patients with acquired heart disease].
    Mikaelian AL; Sherdukalova LF; Gusakova NF; Azatian VG; Minasian LG
    Vestn Akad Med Nauk SSSR; 1987; (9):56-60. PubMed ID: 3673232
    [No Abstract]   [Full Text] [Related]  

  • 4. On the road to the definition of the cardiac miRNome in human disease states.
    Latronico MV; Condorelli G
    J Mol Cell Cardiol; 2008 Aug; 45(2):162-4. PubMed ID: 18619609
    [No Abstract]   [Full Text] [Related]  

  • 5. Is there a role for quinazoline-based α (1)-adrenoceptor antagonists in cardio-oncology?
    Patanè S
    Cardiovasc Drugs Ther; 2014 Dec; 28(6):587-8. PubMed ID: 25230599
    [No Abstract]   [Full Text] [Related]  

  • 6. [Changes in the heart in diabetes].
    Pogátsa G
    Cas Lek Cesk; 1989 Jul; 128(30):929-32. PubMed ID: 2790891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular catecholamine receptors in children: their significance in cardiac disease.
    Buijs EA; Danser AH; Meijer NI; Tibboel D
    J Cardiovasc Pharmacol; 2011 Jul; 58(1):9-19. PubMed ID: 21654329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basic mechanisms of disease progression in the failing heart: the role of excessive adrenergic drive.
    Mann DL
    Prog Cardiovasc Dis; 1998; 41(1 Suppl 1):1-8. PubMed ID: 9715817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of Arzni carbonate mineral baths on the adrenoreactive systems of the myocardium].
    Mirzoian SA; Movsesian TG; Karagian AT
    Vopr Kurortol Fizioter Lech Fiz Kult; 1987; (4):10-5. PubMed ID: 2961123
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in hemocoagulation in altitude-sensitive animals with catecholamine cardiac necrosis].
    Zakharov GA; Ubasheva ChA
    Aviakosm Ekolog Med; 2004; 38(1):53-5. PubMed ID: 15108600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of transforming growth factor-beta in the progression of heart failure.
    Lim H; Zhu YZ
    Cell Mol Life Sci; 2006 Nov; 63(22):2584-96. PubMed ID: 17013566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac histamine and adrenergic receptors.
    McNeill JH
    Proc West Pharmacol Soc; 1981; 24():213-5. PubMed ID: 7255451
    [No Abstract]   [Full Text] [Related]  

  • 13. Characterization of myocardial hypertrophy in prehypertensive spontaneously hypertensive rats: interaction between adrenergic and nitrosative pathways.
    Cabassi A; Dancelli S; Pattoneri P; Tirabassi G; Quartieri F; Moschini L; Cavazzini S; Maestri R; Lagrasta C; Graiani G; Corradi D; Parenti E; Tedeschi S; Cremaschi E; Coghi P; Vinci S; Fiaccadori E; Borghetti A
    J Hypertens; 2007 Aug; 25(8):1719-30. PubMed ID: 17620971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.
    Young MJ
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):174-80. PubMed ID: 18277151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discussion. Catecholamines and heart failure.
    Jpn Circ J; 1971 Aug; 35(8):985-90. PubMed ID: 5171699
    [No Abstract]   [Full Text] [Related]  

  • 16. Regulation of autophagy in the heart in health and disease.
    Kirshenbaum LA
    J Cardiovasc Pharmacol; 2012 Aug; 60(2):109. PubMed ID: 22653420
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relationship between the mosaicism of myocardial damage and the metabolic heterogeneity of myocardiocytes].
    Kalmykova EIu
    Biull Eksp Biol Med; 1977 May; 83(5):625-7. PubMed ID: 884278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucolipotoxicity and the heart.
    Toth PP; Raghavan VA
    Heart Fail Clin; 2012 Oct; 8(4):xvii-xviii. PubMed ID: 22999250
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of cardiopulmonary function and cardiac muscarinic and adrenergic receptor density adaptation in C57BL/6 mice with chronic Trypanosoma cruzi infection.
    Rocha NN; Garcia S; Giménez LE; Hernández CC; Senra JF; Lima RS; Cyrino F; Bouskela E; Soares MB; Ribeiro dos Santos R; Campos de Carvalho AC
    Parasitology; 2006 Dec; 133(Pt 6):729-37. PubMed ID: 16978452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in myocardial gene expression as a basis for cardiomyopathies and heart failure.
    Taylor MR; Bristow MR
    Novartis Found Symp; 2006; 274():73-83; discussion 83-9, 152-5, 272-6. PubMed ID: 17019807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.